Fairvalue-Calculator Fairvalue-Calculator
EN DE

BSM Chemical Co (300796) Fair Value & Analysis

Basic Materials · CN · Market cap 2.5B CNY

Price¥6.87
Fair Value¥1.72
Upside-75.0%
Quality93/100
Evidence: Medium Range ¥1.20 – ¥2.23

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

BSM Chemical Co (300796) currently trades at ¥6.87, while our model-based Fair Value estimate is ¥1.72 — implying the stock looks roughly 75.0% overvalued today. We read business quality at 93/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

BSM Chemical Co.,Ltd. engages in the research and development, and production, and sale of pesticide and pharmaceutical intermediates, pesticide technicals, and pesticide formulations in the Mainland of China and internationally. It offers mononitroxylene isomers and dimethylaniline series reduction products, such as 4-nitro-o-xylene, N-(1-ethylpropyl) -3,4-dimethylaniline, etc. The company was formerly known as Shaoxing BSM Chemical Co., Ltd. BSM Chemical Co.,Ltd. was founded in 2003 and is headquartered in Shaoxing, China.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is BSM Chemical Co (300796) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥1.72 versus a price of ¥6.87 — about −75% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 300796?
Our 21-model fair value for BSM Chemical Co is ¥1.72 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥6.87.
What is the quality score of 300796?
BSM Chemical Co has a Quality Score of 93/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.